If cannabis use overlaps with hearing or seeing things others do not, strong new suspiciousness, confused thinking, or a marked change in behavior, seek medical assessment promptly in Switzerland. Do not assume the experience is harmless because cannabis was involved, or decide from a single episode that someone has a lifelong psychotic disorder. The first tasks are to assess safety, investigate possible causes, and arrange follow-up that addresses both the psychiatric symptoms and cannabis use.
Recognize a reason for assessment without assigning a diagnosis
Psychosis describes experiences such as hallucinations, delusions, and disorganized thinking or speech. The NHS overview of psychosis recommends prompt medical help when these symptoms occur. A person may find it difficult to recognize that their experience differs from other people’s, so a concerned relative sometimes makes the first contact.
Describe what happened in ordinary language. For example, explain that someone believes strangers are sending them personal messages, has stopped sleeping, or has become unable to follow a familiar conversation. Include when the change began and whether the person can eat, drink, manage basic needs, and remain safe. Labels such as paranoid or out of control are less informative than specific observations.
Unusual perceptions or fear after cannabis do not establish the cause of every symptom. The NHS discussion of causes identifies several psychiatric, medical, medication-related, and substance-related possibilities. A proper assessment considers these possibilities rather than treating a reported cannabis exposure as the end of the investigation.
What is known about cannabis and mental health
The Royal College of Psychiatrists describes an association between cannabis use and psychotic illness in its cannabis and mental-health information. This supports taking the combination seriously, but population-level evidence cannot determine the cause of one person’s episode. A clinician needs the individual history, including previous symptoms and other exposures.
Switzerland’s Federal Office of Public Health identifies frequent, substantial, prolonged cannabis use as a particular concern for mental, physical, and social health. It also explains that THC can impair attention, learning, and driving. The FOPH cannabis guidance therefore offers reasons to discuss use openly even when someone does not consider themselves dependent.
Do not turn uncertainty about a product into reassurance. If the composition or strength is unknown, tell the clinician that rather than guessing. A product described as natural, legal, medicinal, or CBD-containing is not evidence that a new psychiatric symptom needs no investigation. Bring any accurate product information you already have, without delaying care to obtain it.
Choose urgent help when the situation is unsafe
Call 144 or 112 for an immediate medical emergency in Switzerland, including serious danger to the person or others, a seizure, collapse, or severe confusion. The official Swiss emergency information lists these routes. Tell the operator about the observed symptoms and known substances. Do not transport someone yourself if their condition makes the journey unsafe.
When the concern is not an immediate emergency, contact a physician or psychiatric service promptly and explain that possible psychosis is involved. An ordinary online addiction-counseling request may not provide the timely medical assessment required. If a service offers only a future appointment, ask what route to use for deterioration in the meantime.
A conversation with the person can focus on distress and practical help without arguing over every belief. You might say that they seem frightened and that you want a doctor to help with the experience. Avoid presenting an internet diagnosis as a fact. If you feel unsafe, step back and obtain professional assistance rather than trying to resolve the situation through confrontation.
Prepare a short account of symptoms and substances
The assessment becomes more useful when the team can compare several timelines: cannabis exposure, sleep, psychiatric symptoms, and changes in functioning. Record only what you know. Distinguish your own observations from what someone else reported. If the person remembers events differently, both accounts may still help the clinician understand what needs clarification.
| Information | Useful detail to bring |
|---|---|
| Recent cannabis use | Approximate dates, product type if known, and whether the pattern changed. |
| Other substances | Alcohol, stimulants, prescribed medicines, nonprescribed tablets, and supplements. |
| Earlier experiences | Similar symptoms before cannabis use or during periods without it. |
| Functioning | Changes in sleep, study, work, relationships, food, or self-care. |
| Previous care | Earlier assessments, hospital stays, prescriptions, and relevant medical history. |
Do not stop prescribed medication to make the symptoms easier to interpret. Tell the treating clinician what has actually been taken and ask them to review it. Similarly, do not use alcohol or someone else’s sedatives to manage distress while waiting. A clinician needs to decide how to address agitation, sleep problems, or withdrawal concerns safely.
If an assessment includes tests, ask what question each is intended to answer and how the result will change care. A medical examination, a substance-use history, and a psychiatric interview have different purposes. Request an explanation you can understand before leaving, especially if several professionals have seen you. It is reasonable to ask which conclusions are established, which remain working possibilities, and what observations would help clarify them at the next visit.
Verified early-assessment routes in Zurich and Basel
PUK’s Zurich Early Psychosis Network, ZEN, describes assessment and follow-up for people aged 18 to approximately 45 with possible risk signs, a suspected or established first episode, or a relatively recent psychosis history. Its published approach combines psychiatric assessment with support for everyday and vocational functioning. Contact the team about eligibility and urgency rather than assuming a cannabis-related presentation is automatically accepted or excluded.
In Basel, UPK’s BEATS early-intervention service describes care for people aged 15–35 at risk of psychosis or experiencing early episodes. The different age range matters: a pathway suitable for an adult in Zurich is not necessarily the route for a teenager in another canton. For someone outside these areas or ranges, ask a local psychiatric service for the age-appropriate equivalent.
These are examples of verified clinical pathways, not a national ranking. They illustrate why it helps to ask for early-psychosis assessment specifically. Our first-episode psychosis guide explains the broader process, including follow-up after the initial concern has settled.
When addiction and psychiatric needs require more intensive care
PDAG publishes a specialized inpatient dual-diagnosis service in Windisch for adults aged 18–64 with substance dependence and serious accompanying psychiatric needs, including psychosis. It describes medical and psychiatric treatment, nursing support, and organization of subsequent psychiatric or psychotherapeutic care. This is a different level of service from an ordinary outpatient counseling appointment.
The treating team should explain why a proposed setting fits current risks and functioning. Someone needing close observation may not be suited to a private residence with visiting clinicians. Someone medically stable may need sustained community treatment rather than hospitalization. The presence of cannabis use alone does not determine the level of care; the full presentation does.
Our inpatient psychiatry and residential rehab comparison helps distinguish the settings. Before any transfer, confirm that the receiving team has reviewed the psychiatric information and can provide the required care.
Keep both concerns in the follow-up plan
NICE’s guideline on psychosis with substance misuse recommends that substance use should not exclude someone from appropriate mental healthcare, and psychosis should not exclude them from substance-use services. This is clinical guidance from the United Kingdom, not a statement that every Swiss clinic has the same admission policy. It is a useful principle when asking teams to coordinate a suitable pathway.
Request a plan that states who reviews psychiatric symptoms, who supports changes in cannabis use, and how they communicate. If one service cannot accept the person, ask what alternative it recommends and who supports the transition. A referral should lead to a named next step rather than leaving the patient to interpret conflicting explanations.
After acute symptoms improve, revisit the reasons cannabis was being used. Someone seeking sleep, relief from distress, social connection, or escape from boredom may need different practical support. The cannabis-use guide discusses assessment and treatment goals without assuming that everyone needs the same program.
Recovery includes ordinary life and an agreed response to change
Plan how study, work, relationships, and appointments will resume at a manageable pace. Ask whether the team can coordinate with educational or employment support, with the person’s permission. A relative can contribute observations while the patient retains a voice in decisions. Agree on what information may be shared and how concerns can be raised.
For families, distinguish support from constant surveillance. Agree on manageable arrangements such as attending an appointment together or helping organize transport, rather than expecting one person to monitor every conversation and activity. Relatives can also ask the service what support is available for their own questions. If accounts differ, record the concern calmly and bring it to the clinician; resolving a disagreement at home is not a prerequisite for getting help.
Before follow-up ends, write down early changes that should prompt contact and the service to call. Keep the explanation provisional where evidence remains uncertain, but make the actions clear. Timely assessment and continued attention to both symptoms and cannabis use are more useful than waiting for certainty about a single cause.